Symphogen raised €21M in a Series D+ round in Jan 2006. The company is based in Ballerup, Denmark. Investors in the round: Essex Woodlands Health Ventures, Gilde Healthcare, Novo A and 2 others. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
